A detailed history of Cresset Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 46,457 shares of EW stock, worth $3.04 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
46,457
Previous 42,579 9.11%
Holding current value
$3.04 Million
Previous $4.07 Million 5.48%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $326,915 - $365,734
3,878 Added 9.11%
46,457 $4.29 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $1.08 Million - $1.43 Million
14,948 Added 54.1%
42,579 $4.07 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $592,354 - $746,418
-9,599 Reduced 25.78%
27,631 $2.11 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $464,314 - $625,832
-6,702 Reduced 15.26%
37,230 $2.58 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $2.97 Million - $3.44 Million
36,434 Added 485.92%
43,932 $4.14 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $171,095 - $194,711
-2,304 Reduced 23.51%
7,498 $620,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $39,887 - $51,064
584 Added 6.34%
9,802 $731,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $134,922 - $175,741
-1,638 Reduced 15.09%
9,218 $762,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $213,914 - $317,211
-2,473 Reduced 18.55%
10,856 $1 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $307,205 - $386,688
-3,013 Reduced 18.44%
13,329 $1.57 Million
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $131,154 - $161,128
1,233 Added 8.16%
16,342 $2.12 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $55,468 - $66,162
539 Added 3.7%
15,109 $1.71 Million
Q2 2021

Aug 10, 2021

BUY
$83.84 - $104.76 $756,152 - $944,830
9,019 Added 162.48%
14,570 $1.51 Million
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $209,682 - $241,635
2,665 Added 92.34%
5,551 $465,000
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $417,450 - $531,232
-5,823 Reduced 66.86%
2,886 $263,000
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $13,169 - $17,138
196 Added 2.3%
8,709 $695,000
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $374,758 - $501,175
6,513 Added 325.65%
8,513 $588,000
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $13,941 - $21,546
266 Added 15.34%
2,000 $377,000
Q4 2019

Feb 10, 2020

SELL
$71.7 - $82.09 $12,977 - $14,858
-181 Reduced 9.45%
1,734 $405,000
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $117,868 - $144,448
1,915 New
1,915 $421,000
Q2 2019

Aug 12, 2019

SELL
$55.74 - $64.41 $145,592 - $168,238
-2,612 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $125,088 - $167,298
2,612 New
2,612 $500,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.